Clinical characteristics of enrolled patients
| Group A: EBUS-centred (N=80) | Group B: EUS-centred (N=80) | p Value | |
|---|---|---|---|
| Age, mean (SD), years | 63.21 (7.91) | 62.94 (8.39) | 0.831 |
| Gender, n (%) | |||
| Men | 63 (78.8) | 57 (71.3) | 0.273 |
| Women | 17 (21.3) | 23 (28.8) | |
| Final diagnosis, n (%) | |||
| NSCLC | 77 (96.25) | 74 (92.5) | 0.330 |
| Squamous cell carcinoma | 28 (35.0) | 26 (32.5) | |
| Adenocarcinoma | 41 (51.3) | 45 (56.3) | |
| LCNEC | 2 (2.5) | 2 (2.5) | |
| Sarcomatoid carcinoma | 1 (1.25) | 0 | |
| Combined LCNEC and adenocarcinoma | 0 | 1 (1.3) | |
| NSCLC, not specified | 5 (6.3) | 0 | |
| Small cell carcinoma | 1 (1.2) | 2 (2.5) | |
| Poorly differentiated carcinoma | 0 | 1 (1.3) | |
| Metastatic thyroid cancer | 0 | 1 (1.3) | |
| Benign lesions | 2 (2.5) | 2 (2.5) | |
| Location of tumours, n (%) | |||
| Right | 48 (60.0) | 46 (57.5) | 0.532 |
| Right upper lobe | 27 (33.8) | 20 (25.0) | |
| Right middle lobe | 7 (8.8) | 8 (10.0) | |
| Right lower lobe | 14 (17.5) | 18 (22.5) | |
| Left | 32 (40.0) | 34 (42.5) | |
| Left upper lobe | 19 (23.8) | 25 (31.3) | |
| Left lower lobe | 13 (16.3) | 9 (11.3) | |
| Clinical T staging by chest CT, n (%) | |||
| T1 | 26 (32.50) | 30 (37.50) | 0.184 |
| T2 | 38 (47.50) | 29 (36.25) | |
| T3 | 14 (17.50) | 21 (26.25) | |
| T4 | 2 (2.50) | 0 | |
| Clinical N staging by PET/CT, n (%) | |||
| N0 | 28 (35.00) | 28 (35.0) | 0.860 |
| N1 | 9 (11.25) | 9 (11.3) | |
| N2 | 26 (32.50) | 22 (27.5) | |
| N3 | 17 (21.25) | 21 (26..3) | |
| Baseline FEV1, mean (SD), L | 2.39 (0.61) | 2.33 (0.64) | 0.524 |
| % predicted, mean (SD), % | 93.5 (20.5) | 94.1 (19.6) | 0.844 |
| Baseline systolic BP, mean (SD), mm Hg | 143.2 (20.5) | 142.7 (22.2) | 0.878 |
| Baseline diastolic BP, mean (SD), mm Hg | 81.5 (12.4) | 80.8 (10.8) | 0.712 |
| Baseline heart rate, mean (SD), n/min | 74.4 (5.8) | 78.0 (16.5) | 0.159 |
| Baseline SaO2, mean (SD), % | 99.7 (0.8) | 99.8 (0.6) | 0.157 |
BP, blood pressure; EBUS, endobronchial ultrasound; EUS, endoscopic ultrasound; FEV1, forced expiratory volume in 1 s; LCNEC, large cell neuroendocrine carcinoma; NSCLC, non-small cell carcinoma; PET, positron emission tomography; SaO2, oxygen saturation.